Open AccessThe HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells
Author(s) -
L. Allegri,
F. Baldan,
S. Roy,
J. Aubé,
D. Russo,
S. Filetti,
G. Damante
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/keth-pn24
Subject(s) - downregulation and upregulation , thyroid cancer , mad2 , cancer research , cancer , medicine , chemistry , cell cycle , cell cycle checkpoint , gene , biochemistry